García-Morillo José Salvador, Bernabeu-Wittel Máximo, Ollero-Baturone Manuel, Aguilar-Guisad Manuela, Ramírez-Duque Nieves, González de la Puente Miguel Angel, Limpo Pilar, Romero-Carmona Susana, Cuello-Contreras José Antonio
Unidad Clínica de Atención Médica Integral, Servicio de Medicina Interna, Hospitales Universitarios Virgen del Rocío, 41013 Sevilla, España.
Med Clin (Barc). 2005 Jun 4;125(1):5-9. doi: 10.1157/13076399.
Our objective was to assess the incidence and clinical features of patients with numerous disorders--comorbidity patients (CP)--and to clinically validate the CP criteria defined by a panel of experts (patients with 2 or more chronic diseases, distributed into seven categories).
Prospective observational study of all patients, attended in internal medicine areas of a tertiary teaching hospital, during June 2003. Patients were stratified in 3 cohorts: CP, palliative, and general (GE). Incidence of CP, functional evaluation (at baseline, at admission, and at discharge), and burden of hospital care (by means of urgent and programmed visits, as well as episodes of hospitalization) in the last 12 months were analyzed. A multivariate analysis of predictors of survival and functional deterioration (fall in Barthel's scale > or = 10 points between baseline-discharge values) was performed in the CP cohort.
339 patients (CP cohort: 132; palliative: 52; GE: 155) were included. The overall incidence was 38.9/100 admissions/month. CP were older (75 [11] vs 67 [16]); had higher mortality (19.3% vs 6.1%; relative risk [RR]: 3.66 [95% confidence interval [CI], 1.65-8.13]; lower functional ability at baseline (45 vs 95), at admission (20 vs 75), and at discharge (20 vs 95); higher rates of significant functional deterioration (16% vs 7%; RR = 2.47 [95% CI, 1.15-5.35]); and required more burden of hospital care by means of urgent care (3.6 [3.4] episodes vs 2.4 [1.9]), and hospitalizations (1.9 [1.3] vs 1.5 [1]) than GE patients. Chronic digestive/hepatic diseases (odds ratio [OR] = 48.3 [2.4-980.9], peripheric vascular disease/diabetes with visceral involvement (OR = 5.6 [CI 95%, 1.1-28.6]), and better functional ability at admission were associated with survival. Female gender (OR ) 46.6 [CI 95%, 4.5-486.9]), chronic lung disease (OR = 8.9 [CI 95%, 1.2-64]), and neurologic disease with disability (OR = 8 [CI 95%, 1.1-58.9]), were associated with significant functional deterioration during hospital stay.
The defined CP criteria were highly accurate in detecting a population of patients with high attention in Internal Medicine areas, high mortality rates, clinical frailty (more need of hospital care), and significant functional deterioration. Barthel's scale identified correctly this group of patients, and was independently associated with survival.
我们的目标是评估患有多种疾病的患者——合并症患者(CP)的发病率和临床特征,并对由一组专家定义的CP标准(患有2种或更多慢性疾病,分为七类)进行临床验证。
对2003年6月在一家三级教学医院内科就诊的所有患者进行前瞻性观察研究。患者被分为3组队列:CP组、姑息治疗组和普通组(GE)。分析了CP的发病率、功能评估(在基线、入院时和出院时)以及过去12个月的医院护理负担(通过紧急和计划性就诊以及住院次数)。对CP队列中生存和功能恶化的预测因素进行了多变量分析(Barthel量表在基线 - 出院值之间下降≥10分)。
纳入339例患者(CP队列:132例;姑息治疗组:52例;GE组:155例)。总体发病率为38.9/100次入院/月。CP组患者年龄更大(75[11]岁对67[16]岁);死亡率更高(19.3%对6.1%;相对风险[RR]:3.66[95%置信区间[CI],1.65 - 8.13]);基线时(45对95)、入院时(20对75)和出院时(20对95)功能能力较低;显著功能恶化率更高(16%对7%;RR = 2.47[95%CI,1.15 - 5.35]);与GE组患者相比,通过紧急护理(3.6[3.4]次对2.4[1.9]次)和住院(1.9[1.3]次对1.5[1]次)所需的医院护理负担更重。慢性消化/肝脏疾病(优势比[OR] = 48.3[2.4 - 980.9])、外周血管疾病/伴有内脏受累的糖尿病(OR = 5.6[CI 95%,1.1 - 28.6])以及入院时较好的功能能力与生存相关。女性(OR = 46.6[CI 95%,4.5 - 486.9])、慢性肺部疾病(OR = 8.9[CI 95%,1.2 - 64])和伴有残疾的神经系统疾病(OR = 8[CI 95%,1.1 - 58.9])与住院期间显著的功能恶化相关。
所定义的CP标准在检测内科领域中需要高度关注、高死亡率、临床虚弱(更需要医院护理)和显著功能恶化的患者群体方面具有高度准确性。Barthel量表正确识别了这组患者,并且与生存独立相关。